Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

STAT+: Early results for Alterome’s KRAS drug for pancreas, lung and colon cancer arrive

Alterome presented preliminary Phase 1 results of its drug “selectively” targeting a range of KRAS mutations — drivers of cancers in the pancreas, lung and colon:

STAT+: Early results for Alterome’s KRAS drug for pancreas, lung and colon cancer arrive

We haven't written up this one. STAT News has the full story — the link below goes straight to it.

Read the original at statnews.com →

More in Health & Medicine

More from Friday 20 November →